Epilepsy drug safety test expands to 700 patients
NCT ID NCT07287163
Summary
This study continues testing vormatrigine, an investigational medication for epilepsy, to evaluate its long-term safety in adults. It enrolls 700 participants who previously took vormatrigine in earlier trials and continue taking it to control their seizures. The main goal is to monitor for side effects and see how well people tolerate the medication over an extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL SEIZURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Praxis Research Site
Miami Lakes, Florida, 33016, United States
-
Praxis Research Site
Naples, Florida, 34116, United States
-
Praxis Research Site
Lafayette, Louisiana, 70508, United States
-
Praxis Research Site
Bethesda, Maryland, 20817, United States
-
Praxis Research Site
Chesterfield, Missouri, 63005, United States
-
Praxis Research Site
Amherst, New York, 14226, United States
-
Praxis Research Site
Middletown, New York, 10941, United States
-
Praxis Research Site
El Paso, Texas, 79912, United States
-
Praxis Research Site
Houston, Texas, 77058, United States
-
Praxis Research Site
Bielefeld, 33617, Germany
-
Praxis Research Site
Tübingen, 72076, Germany
-
Praxis Research Site
Milan, 20133, Italy
-
Praxis Research Site
Pavia, 27100, Italy
-
Praxis Research Site
Bydgoszcz, 85163, Poland
-
Praxis Research Site
Katowice, 40123, Poland
-
Praxis Research Site
Barcelona, 08003, Spain
-
Praxis Research Site
Madrid, 28040, Spain
-
Praxis Research Site
Málaga, 29010, Spain
-
Praxis Research Site
Terrassa, 08222, Spain
-
Praxis Research Site
Valencia, 46026, Spain
Conditions
Explore the condition pages connected to this study.